Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000452

Drug Information
NameAZD1152    
CompanyAstraZeneca    
IndicationAcute Myeloid Leukemia, Haematological malignanciesPhase II    
Myeloid LeukemiaPhase I/II    
CAS NumberCAS 722544-51-6
FormularC26H30FN7O3    
ClinicalTrials.govNCT00497991;    
NCT00952588;    
TargetAurora A kinase Inhibitor[1]
Aurora A kinase Multitarget[1]
Aurora B kinaseInhibitor[1]
Aurora B kinaseMultitarget[1]
Ref 1AstraZeneca. Product Development Pipeline. January 29 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543